Medline Industries, LP has been the subject of 242 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre.
Medline Industries, LP: 0 warning letters, 242 recalls, 0 approval records, 0 Form 483s.
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.
Side by side
Medline Industries, LP — Warning letters0
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Warning letters1
Medline Industries, LP — Recalls242
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Recalls0
Medline Industries, LP — Approval records0
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Approval records0
Medline Industries, LP — Form 483s0
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Form 483s0
Timeline
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre
Most recent FDA action: April 29, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Medline Industries, LP vs Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/medline-industries-lp-vs-mukesh-b-chandre-m-d-mbbs-ashirwad-hospital-and-research-centre
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗